Abstract
Results TS patients exhibited a higher frequency of CD4FOXP3 Tregs among their lymphocytes (mean 2.06 vs. 1.52%, P = 0.005) and FOXP3 Tregs among their CD4 T cells (7.44 vs. 4.19%, P < 0.001) compared to controls. The expression of inhibitory CTLA-4 in the Tregs of TS patients was also significantly higher (mean fluorescence intensity = 214.1 vs. 184.6, P = 0.003). The frequency of Tregs expressing GITR, CXCR3, and CCR4CCR6 was comparable between the two groups. However, the ability of Tregs to suppress the in vitro proliferation of autologous CD4 CD25 T cells was significantly impaired in TS patients compared to controls (P < 0.05 at a 0.1:1 ratio of Tregs to target cells, P < 0.01 at 0.25:1, 0.5:1, and 1:1).
Highlights
Abundant CD4+FOXP3+ regulatory T cells fail to suppress the proliferation of T cells in patients with Turner syndrome
Submit your manuscript to BioMed Central and take full advantage of:
Summary
Young Ah Lee1*, Hang-Rae Kim[2,3], Jeong Seon Lee[1], Haewoon Jung[1], Hwa Young Kim[1], Kyung Min Lee[1], Ji Hyun Sim[2], Doo Hyun Chung[3,4,5], Choong Ho Shin[1], Sei Won Yang[1]. From 8th APPES Biennial Scientific Meeting Darwin, Australia. Context Why Turner syndrome (TS) patients are predisposed to autoimmune disease remains unclear
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
